Mira Hormone Monitor, Mira Android App Missing authentication for critical function
CVSS score
8.7
EPSS probability
%0.4
Risk score
0.0
Published
2 mo ago
Resmî kaynaklarda yeterli kanıt bulunamadı. Bu sonuç “yama yok” anlamına gelmez.
Impact on My Inventory
Only the personal products you have added to your account are assessed; an organisation's inventory does not appear here.
Checking session…
Vulnerability description
DayBreach CVE AI Research
CVE-2026-66875 has vendor, distribution, patch and security-source records on file. We can compare them and prepare an explanation linked to the evidence.
In the Mira hormone monitor device firmware v1.7.1.47 build 01070147, a remote unauthenticated attacker within BLE range (approximately 10–30 meters) can silently rebind the device to an attacker-controlled account, extract stored hormone measurements in cleartext, cause a denial-of-service via malformed or undocumented command opcodes, and passively track the user via a static random BLE address that never rotates.
IMPACT: Affected Products and Software
Affected Products
The following products are affected by CVE-2026-66875 vulnerability. Where our threat engine knows the exact affected versions, they are listed below.
RED HAT CSAF/VEX: Product Impact Check
SCORING: CVSS from Multiple Sources
CVSS Scores
The Common Vulnerability Scoring System is a standardised framework for assessing the severity of vulnerabilities in software and systems. We collect and display CVSS scores from several sources for each CVE.
| SCORE | VERSION | SEVERITY | VECTOR | SOURCE |
|---|---|---|---|---|
| 8.8 | CVSS V31 | HIGH | CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H | NVD |
| 8.8 | CVSS V3_1 | HIGH | CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H | CVE CNA |
| 8.7 | CVSS V40 | HIGH | CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X | NVD |
| 8.7 | CVSS V4_0 | HIGH | CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N | CVE CNA |
Patch and Remediation Guide
Solution & Remediation Advisory
İncelenen resmî kaynaklarda yama durumu doğrulanamadı. Bu sonuç “yama yok” anlamına gelmez.
Public exploit and active exploitation status
Verified exploit intelligence
No verified public PoC, exploit repository or Metasploit module has been found for this CVE yet.
Weakness Classification and Attack Patterns (CWE & CAPEC)
CWE - Common Weakness Enumeration
While CVE identifies specific instances of vulnerabilities, CWE categorises the common flaws or weaknesses that can lead to vulnerabilities. CVE-2026-66875 is associated with the following CWEs:
Common Attack Pattern Enumeration and Classification (CAPEC)
Common Attack Pattern Enumeration and Classification (CAPEC) stores attack patterns, which are descriptions of the common attributes and approaches employed by adversaries to exploit the CVE-2026-66875 weaknesses.
Attack Vector and Accessibility
Official Sources and Advisories
CVSS Vector Radar Chart
8.7 / 10Vulnerability Scoring Details
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:NYama durumu bilinmiyor
Weakness Type (CWE & CAPEC)
Similar Vulnerabilities
Mira Hormone Monitor, Mira Android App Weak Authentication
Mira Hormone Monitor, Mira Android App Use of Hard-coded Credentials
Mira Hormone Monitor, Mira Android App Improper restriction of excessive authentication attempts
Mira Hormone Monitor, Mira Android App Use of GET request method with sensitive query strings
Mira Hormone Monitor, Mira Android App Missing authentication for critical function
Mira Hormone Monitor, Mira Android App Authentication bypass by spoofing
Get this vulnerability through the API
Affected products, version ranges, exploitation status and patch information in a single request, with a free key.
curl -H "x-api-key: $DAYBREACH_API_KEY" \ "https://api.enginteksut.com.tr/api/v1/intel/cves/CVE-2026-66875"